Cell‐Based Bioassay to Screen Environmental Chemicals and Human Serum for Total Glucocorticogenic Activity

Glucocorticoids are steroid hormones that have systemic effects that are mediated by the glucocorticoid receptor. Environmental chemicals that disrupt glucocorticoid receptor signaling and/or glucocorticoid homeostasis could adversely affect the health of human and nonhuman vertebrates. A major challenge in identifying environmental chemicals that alter glucocorticoid receptor signaling and/or glucocorticoid homeostasis is a lack of adequate screening methods. We developed a cell‐based bioassay to measure total glucocorticogenic activity (TGA) of environmental chemicals and human serum. Human MDA‐MB‐231 breast cancer cells were stably transfected with a luciferase reporter gene driven by 3 tandem glucocorticoid‐response elements. Dose–response curves for 6 glucocorticoids and 4 non‐glucocorticoid steroid hormones were generated to evaluate the specificity of the bioassay. Cells were also optimized to measure TGA of 176 structurally diverse environmental chemicals and human serum samples in a high‐throughput format. Reporter activity was glucocorticoid‐specific and induced 400‐fold by 1 μM dexamethasone. Furthermore, 3 of the screened chemicals (3,4,4′‐trichlorocarbanilide, isopropyl‐N‐phenylcarbamate, and benzothiazole derivative 2‐[4‐chlorophenyl]‐benzothiazole) potentiated cortisol‐induced glucocorticoid receptor activity. Serum TGA estimates from the bioassay were highly correlated with a cortisol enzyme‐linked immunosorbent assay. The present study establishes an in vitro method to rapidly screen environmental chemicals and human serum for altered glucocorticogenic activity. Future studies can utilize this tool to quantify the joint effect of endogenous glucocorticoids and environmental chemicals. Environ Toxicol Chem 2021;40:177–186. © 2020 SETAC

[1]  H. Kohler,et al.  Glucocorticoids promote breast cancer metastasis , 2019, Nature.

[2]  S. Takeuchi,et al.  Profiling of bisphenol A and eight its analogues on transcriptional activity via human nuclear receptors. , 2019, Toxicology.

[3]  C. McHale,et al.  Using Exposomics to Assess Cumulative Risks from Multiple Environmental Stressors , 2018, Unraveling the Exposome.

[4]  Benoît Y. Michel,et al.  Imidazo[2,1-b]benzothiazol Derivatives as Potential Allosteric Inhibitors of the Glucocorticoid Receptor. , 2018, ACS medicinal chemistry letters.

[5]  Paula I. Johnson,et al.  The Florence Statement on Triclosan and Triclocarban , 2017, Environmental health perspectives.

[6]  L. Gulliver.  Xenobiotics and the Glucocorticoid Receptor , 2017, Toxicology and applied pharmacology.

[7]  Tiehua Zhang,et al.  In vitro and in silico assessment of the structure-dependent binding of bisphenol analogues to glucocorticoid receptor , 2017, Analytical and Bioanalytical Chemistry.

[8]  K. Yamamoto,et al.  Glucocorticoid receptor control of transcription: precision and plasticity via allostery , 2017, Nature Reviews Molecular Cell Biology.

[9]  E. John,et al.  Association of lifestyle and demographic factors with estrogenic and glucocorticogenic activity in Mexican American women. , 2016, Carcinogenesis.

[10]  B. Coull,et al.  Longitudinal associations of age and prenatal lead exposure on cortisol secretion of 12–24 month-old infants from Mexico City , 2016, Environmental Health.

[11]  S. Snyder,et al.  Balancing the Budget: Accounting for Glucocorticoid Bioactivity and Fate during Water Treatment. , 2016, Environmental science & technology.

[12]  Rui Liu,et al.  Endocrine-Disrupting Effects of Pesticides through Interference with Human Glucocorticoid Receptor. , 2016, Environmental science & technology.

[13]  Florent Baty,et al.  Dose-Response Analysis Using R , 2015, PloS one.

[14]  Martyn T. Smith,et al.  Using exposomics to assess cumulative risks and promote health , 2015, Environmental and molecular mutagenesis.

[15]  H. Takigami,et al.  Detection of glucocorticoid receptor agonists in effluents from sewage treatment plants in Japan. , 2015, The Science of the total environment.

[16]  W. Rainey,et al.  Cell-Based Assays for Screening Androgen Receptor Ligands , 2015, Seminars in Reproductive Medicine.

[17]  M. Sollner Dolenc,et al.  Screening of bisphenol A, triclosan and paraben analogues as modulators of the glucocorticoid and androgen receptor activities. , 2015, Toxicology in vitro : an international journal published in association with BIBRA.

[18]  Ksenia J. Groh,et al.  Endocrine disrupting compounds affecting corticosteroid signaling pathways in Czech and Swiss waters: potential impact on fish. , 2014, Environmental science & technology.

[19]  Rosalind J Wright,et al.  Relationships between lead biomarkers and diurnal salivary cortisol indices in pregnant women from Mexico City: a cross-sectional study , 2014, Environmental Health.

[20]  M. Sollner Dolenc,et al.  Molecular docking revealed potential disruptors of glucocorticoid receptor-dependent reporter gene expression. , 2014, Toxicology letters.

[21]  J. Cidlowski,et al.  The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease. , 2013, The Journal of allergy and clinical immunology.

[22]  A. Kolkman,et al.  Sample preparation for combined chemical analysis and in vitro bioassay application in water quality assessment. , 2013, Environmental toxicology and pharmacology.

[23]  Z. Dvořák,et al.  Construction and characterization of a reporter gene cell line for assessment of human glucocorticoid receptor activation. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[24]  G. Sabino,et al.  Environmental exposure to organophosphate pesticides: assessment of endocrine disruption and hepatotoxicity in pregnant women. , 2012, Ecotoxicology and environmental safety.

[25]  A. Todd,et al.  Increased Lead Biomarker Levels Are Associated with Changes in Hormonal Response to Stress in Occupationally Exposed Male Participants , 2011, Environmental health perspectives.

[26]  S. Lightman,et al.  Understanding drug resistance to biologic therapy Dynamic regulation of glucocorticoid signalling in health and disease RHEUMATOLOGY , 2011 .

[27]  D. Ray,et al.  Serum regulates cortisol bioactivity by corticosteroid‐binding globulin‐dependent and independent mechanisms, as revealed by combined bioassay and physicochemical assay approaches , 2011, Clinical endocrinology.

[28]  M. Nielen,et al.  Recombinant cell bioassays for the detection of (gluco)corticosteroids and endocrine-disrupting potencies of several environmental PCB contaminants , 2011, Analytical and bioanalytical chemistry.

[29]  P. Bartůněk,et al.  Two Panels of Steroid Receptor Luciferase Reporter Cell Lines for Compound Profiling , 2011, Combinatorial chemistry & high throughput screening.

[30]  K. Chapman,et al.  The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights , 2011, Molecular and Cellular Endocrinology.

[31]  Annemarie P van Wezel,et al.  High-resolution mass spectrometric identification and quantification of glucocorticoid compounds in various wastewaters in the Netherlands. , 2010, Environmental science & technology.

[32]  M. Silverberg,et al.  Glucocorticoid bioactivity does not predict response to steroid therapy in severe pediatric ulcerative colitis , 2010, Inflammatory bowel diseases.

[33]  M. Denison,et al.  Toxicology in the Fast Lane: Application of High-Throughput Bioassays to Detect Modulation of Key Enzymes and Receptors , 2009, Environmental health perspectives.

[34]  A. Odermatt,et al.  Glucocorticoid and mineralocorticoid action: why should we consider influences by environmental chemicals? , 2008, Biochemical pharmacology.

[35]  A. Odermatt,et al.  Dibutyltin Disrupts Glucocorticoid Receptor Function and Impairs Glucocorticoid-Induced Suppression of Cytokine Production , 2008, PloS one.

[36]  Adam Yasgar,et al.  Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[37]  G. Flik,et al.  Evolution of glucocorticoid receptors with different glucocorticoid sensitivity. , 2006, The Journal of endocrinology.

[38]  T. Raivio,et al.  Circulating glucocorticoid bioactivity in the preterm newborn after antenatal betamethasone treatment. , 2004, The Journal of clinical endocrinology and metabolism.

[39]  B. van der Burg,et al.  A novel specific bioassay for the determination of glucocorticoid bioavailability in human serum , 2003, Clinical endocrinology.

[40]  J. Mullol,et al.  Expression of glucocorticoid receptor alpha- and beta-isoforms in human cells and tissues. , 2002, American journal of physiology. Cell physiology.

[41]  T. Raivio,et al.  Transactivation assay for determination of glucocorticoid bioactivity in human serum. , 2002, The Journal of clinical endocrinology and metabolism.

[42]  L. Gray,et al.  A novel cell line, MDA-kb2, that stably expresses an androgen- and glucocorticoid-responsive reporter for the detection of hormone receptor agonists and antagonists. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[43]  R. Sapolsky,et al.  How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. , 2000, Endocrine reviews.

[44]  Bruce Mcewen,et al.  Stress, Adaptation, and Disease: Allostasis and Allostatic Load , 1998, Annals of the New York Academy of Sciences.

[45]  Jian Wang,et al.  Androgen and Glucocorticoid Receptor Heterodimer Formation , 1997, The Journal of Biological Chemistry.

[46]  D. Bishop,et al.  Heritability of variation of plasma cortisol levels. , 1988, Metabolism: clinical and experimental.

[47]  R. Evans,et al.  The steroid and thyroid hormone receptor superfamily. , 1988, Science.

[48]  A K Thilagar,et al.  Steroid receptor analyses of nine human breast cancer cell lines. , 1978, Cancer research.

[49]  W. Buchanan,et al.  Plasma corticosteroids in healthy twin pairs. , 1969, Journal of medical genetics.

[50]  Steven Ripp,et al.  Detection of organic compounds with whole-cell bioluminescent bioassays. , 2014, Advances in biochemical engineering/biotechnology.

[51]  S. Smale,et al.  Luciferase assay. , 2010, Cold Spring Harbor protocols.

[52]  D. Grobbee,et al.  Interperson variability but intraperson stability of baseline plasma cortisol concentrations, and its relation to feedback sensitivity of the hypothalamo-pituitary-adrenal axis to a low dose of dexamethasone in elderly individuals. , 1998, The Journal of clinical endocrinology and metabolism.